130: Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS Trust. (January 2015) - Hill, E.; Higgins, G.; Vallis, K.; Stuart, R.; Drummond, L.; Buckle, A.; Panakis, N.